by Pauline T. Mayer
The 37th Annual VEITHsymposium will kick-off two great programs, WOUNDS and Endovenous Management of Varicose Veins on Wednesday, November 17 at the Hilton New York. World-renowned experts will present their opinions, findings and other significant data to an audience of vascular surgeons and vascular specialists with an interest in these respective areas.This year’s WOUND course directors will include Dr. Dieter Mayer, Head of Wound Care at the Clinic of Cardiovascular Surgery in Zurich, Switzerland, Dr. Bauer Sumpio, Yale University School of Medicine in New Haven, Connecticut and Dr. Stephen Kravitz, Executive Director of the American Professional Wound Care Association. Course directors of the endovenous management of varicose veins session include Dr. Jose Almeida, University of Miami- Jackson Memorial Hospital and Dr. Lowell Kabnick from New York University Medical Center.
“This year’s WOUNDS and vein program will have the most current hot topics and lively debates guaranteed to spark the interest of many who have already begun to register. Be prepared to ask questions during the moderated sessions,” notes Dr. Frank J. Veith, Professor of Surgery at Cleveland Clinic and chairman of the 37th Annual VEITHsymposium. Both programs are in their fifth year and are standing room only.
WOUNDS at VEITHsymposium offers a unique and exciting format to learn the most current information about what is new and important in the treatment of chronic wounds. Rapid-fire presentations from experts will provide the latest advances, controversies, new techniques and other timely information. Topics to be addressed include treatment of pyoderma gangraenosum with imunosuppression and a bi-layered skin substitute, keratinocytes in wound healing, evidenced based medicine in vascular surgery and wound care, an introduction to the National Pressure Ulcer Advisory Panel, just to name a few.
Those attending the Endovenous Management of Varicose Veins at VEITHsymposium will listen to discussions on how to approach the “Comparative Effectiveness” issue, a review of randomized controlled trials comparing endovenous thermal ablation with modern extirpation surgery for saphenous incompetence, a debate on C?, C5, C? refluxing truncal veins, a detailed discussion on a randomized trial comparing RF, laser, foam sclerotherapy, stripping in varicose veins and much more.
Other timely topics discussed throughout the 5-day event include interventional therapies for the treatment of DCVT, including ultrasound-assisted thrombolysis, catheter-directed thrombolysis. The complete 5-day program features sessions on new developments in SFA and crural artery treatments and management of CLI, a careful analysis and subanalysis of CREST and other CAS vs. CEA trials, a resume of all the EVAR vs. open repair trials with standard elective AAAs, a careful analysis of new, better devices for TEVAR, hemodialysis access, analysis of new developments in the medical treatment of arteriosclerosis in vascular patients with statins, beta blockers and other drugs and so much more. The 2010 VEITHsymposium program features over 600 rapid-fire presentations offered in 67 sessions throughout the five-day event and has become a “must attend” symposium for vascular surgeons and vascular specialists throughout the world. New York City boasts wonderful entertainment for the family, including Broadway, trips to the Museum of Natural History, MOMA, incredible shopping on 5th Avenue, including FAO Schwartz, a world-famous toy emporium, and great ethnic restaurants.
To learn more and to register, visit www.veithsymposium.org.
